ConductScience.org, home
A Study of the Effectiveness of Fampridine in Improving Upper Limb Function in MS
API referenceFor AI assistants

Trial · NCT02208050

Participant flow30

How many started, completed or left each group, period by period.

1 to 20 of 30

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Baseline Assessment Period: 2 WeeksSTARTEDGroup A: Fampridine Followed by Placebo36
Baseline Assessment Period: 2 WeeksSTARTEDGroup B: Placebo Followed by Fampridine28
Baseline Assessment Period: 2 WeeksCOMPLETEDGroup A: Fampridine Followed by Placebo36
Baseline Assessment Period: 2 WeeksCOMPLETEDGroup B: Placebo Followed by Fampridine28
Baseline Assessment Period: 2 WeeksNOT COMPLETEDGroup A: Fampridine Followed by Placebo0
Baseline Assessment Period: 2 WeeksNOT COMPLETEDGroup B: Placebo Followed by Fampridine0
Treatment Period 1: 8 Weeks TreatmentSTARTEDGroup A: Fampridine Followed by Placebo36
Treatment Period 1: 8 Weeks TreatmentSTARTEDGroup B: Placebo Followed by Fampridine28
Treatment Period 1: 8 Weeks TreatmentCOMPLETEDGroup A: Fampridine Followed by Placebo36
Treatment Period 1: 8 Weeks TreatmentCOMPLETEDGroup B: Placebo Followed by Fampridine28
Treatment Period 1: 8 Weeks TreatmentNOT COMPLETEDGroup A: Fampridine Followed by Placebo0
Treatment Period 1: 8 Weeks TreatmentNOT COMPLETEDGroup B: Placebo Followed by Fampridine0
Washout Period 1: 2 WeeksSTARTEDGroup A: Fampridine Followed by Placebo36
Washout Period 1: 2 WeeksSTARTEDGroup B: Placebo Followed by Fampridine28
Washout Period 1: 2 WeeksCOMPLETEDGroup A: Fampridine Followed by Placebo35
Washout Period 1: 2 WeeksCOMPLETEDGroup B: Placebo Followed by Fampridine28
Washout Period 1: 2 WeeksNOT COMPLETEDGroup A: Fampridine Followed by Placebo1
Washout Period 1: 2 WeeksNOT COMPLETEDGroup B: Placebo Followed by Fampridine0
Treatment Period 2: 8 Weeks TreatmentSTARTEDGroup A: Fampridine Followed by Placebo35
Treatment Period 2: 8 Weeks TreatmentSTARTEDGroup B: Placebo Followed by Fampridine28

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02208050/flow

API referenceFor AI assistants